… Immunocompromised individuals and particularly those with hematologic malignancies
are at increased risk for SARS-CoV-2-associated morbidity and mortality due to immunologic …

… that SARS-CoV-2 infection in immunocompromised populations might propagate SARS-CoV-2 …
Immunocompromised populations include a variety of subpopulations, such as organ …

… Here we describe an asymptomatic, immunocompromised individual persistently testing
positive for SARS-CoV-2 by qRT-PCR who was infected during the early phase of SARS-CoV-2 …

… For another 5 studies, SARS-CoV-2 was isolated … ; SARS-CoV-2 was isolated up to
day 32 in one study. Two studies identified immunocompromised patients from whom SARS-CoV-2 …

… immunocompromised patients are not yet available. Here, we prospectively monitored the
dynamic change in SARS-CoV-… SARS-CoV-2 in accordance with the WHO technical guidance. …

… Many individuals mount nearly identical antibody responses to SARS-CoV-2. To gain …
virus evolution in a persistently infected immunocompromised individual. We use antibody Fab/…

… We assume that, for each pathogen, the immunocompromised host will demonstrate reduced
resistance to infection, atypical clinical signs and symptoms, more rapid progression, and …

… infectiousness and shedding of SARS‐CoV‐2 in the immunocompromised patients is scarce,
… regarding transmissibility and replication of SARS‐CoV‐2 in immunosuppressed patients. …

… Even though it has been reported that the viral burden of SARS-CoV-2 measured in upper
… We report a case of immunocompromised patient with malignant lymphoma, who had …

… After identifying immunocompromised patients with viral rebound under treatment with
bamlanivimab, we characterized the SARS-CoV-2-isolates by whole genome sequencing. Viral …